In contrast, high HIF2A mRNA expressing tumours displayed downregulation of scores for interferon-γ and for APM2 (measuring MHC class II antigen presentation), consistent with the upregulation of these features in mouse ccRCC tumours lacking HIF-2α. This evidence concerns the gene ADIRF and nonpapillary renal cell carcinoma.